| CLASS | PANEL.DRUG/TOX | LP29683-7 |
| COMPONENT | Doxepin & Nordoxepin panel | LP36365-2 |
| PROPERTY | - | LP6769-6 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Doxepin and Nordoxepin panel | Serum or Plasma | Drug and Toxicology Panels | LP392061-0 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Order | |
| PanelType | Panel | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Doxepin and Nordoxepin panel - Serum or Plasma |
| LONG_COMMON_NAME | en-US | Doxepin and Nordoxepin panel - Serum or Plasma |
| SHORTNAME | en-US | Doxepin+Nor Pnl SerPl |
| ConsumerName | en-US | Doxepin and Nordoxepin panel, Blood |
| SHORTNAME | pt-BR | Doxepin+Nor Pnl SerPl-mCnc |
| LONG_COMMON_NAME | fr-FR | Doxépine et nordoxépine panel [-] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Doxepine & nordoxepine panel in serum of plasma |
| LONG_COMMON_NAME | es-MX | Panel de Doxepina y Nordoxepina: Suero o Plasma : Punto temporal: -: Cuantitativo: |
LOINC Version: 2.81
FHIR